Literature DB >> 6196447

Spontaneous and experimental neuritis and the distribution of the myelin protein P2 in the nervous system.

M Kadlubowski, R A Hughes, N A Gregson.   

Abstract

The P2 contents of nervous tissues from the human, rabbit, guinea pig, and Lewis rat were measured by radioimmunoassay. The ventral spinal roots contained more P2 than any other tissue. Human dorsal roots and peripheral nerves contained 41-65% of the amount in human ventral roots. Human olfactory and optic nerves and brain contained 1.1-2.7%, spinal cord, 2.8%, cranial nerve VIII, 11%, and cerebral grey matter, 0%. The relative amounts in the rabbit nervous system were similar except that the spinal cord contained 20% of the amount in the ventral roots. Qualitative estimates in the guinea pig showed that the spinal roots and peripheral nerves contained more P2 than the spinal cord, and that none was present in the brain. In the Lewis rat, P2 could be detected in the spinal roots and peripheral nerves but not in the CNS. The distribution of P2 in the human nervous system parallels the incidence and severity of lesions in acute polyradiculoneuritis. It also explains the absence of any lesions in the CNS when experimental allergic neuritis is induced in the Lewis rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6196447     DOI: 10.1111/j.1471-4159.1984.tb09707.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  The differentiation of peripheral effector neuron failure from acute brain stem dysfunction in a critically ill patient.

Authors:  P G Bain; G Harwood; G E Holder; B M Evans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

2.  Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Authors:  Sophie Belin; Francesca Ornaghi; Ghjuvan'Ghjacumu Shackleford; Jie Wang; Cristina Scapin; Camila Lopez-Anido; Nicholas Silvestri; Neil Robertson; Courtney Williamson; Akihiro Ishii; Carla Taveggia; John Svaren; Rashmi Bansal; Markus H Schwab; Klaus Nave; Pietro Fratta; Maurizio D'Antonio; Yannick Poitelon; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

3.  The Role of Peripheral Myelin Protein 2 in Remyelination.

Authors:  Mark Stettner; Jennifer Zenker; Fabian Klingler; Fabian Szepanowski; Hans-P Hartung; Anne K Mausberg; Christoph Kleinschnitz; Roman Chrast; Bernd C Kieseier
Journal:  Cell Mol Neurobiol       Date:  2017-04-26       Impact factor: 5.046

4.  A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.

Authors:  T Kanda; H Hayashi; H Tanabe; T Tsubaki; M Oda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

5.  A prospective study of acute idiopathic neuropathy. III. Immunological studies.

Authors:  J B Winer; I A Gray; N A Gregson; R A Hughes; S Leibowitz; P Shepherd; W A Taylor; V Yewdall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

6.  De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.

Authors:  William W Motley; Paulius Palaima; Sabrina W Yum; Michael A Gonzalez; Feifei Tao; Julia V Wanschitz; Alleene V Strickland; Wolfgang N Löscher; Els De Vriendt; Stefan Koppi; Livija Medne; Andreas R Janecke; Albena Jordanova; Stephan Zuchner; Steven S Scherer
Journal:  Brain       Date:  2016-03-23       Impact factor: 13.501

7.  Monoclonal antibody selectively reactive with myelin sheaths of the peripheral nervous system in paraffin-embedded material.

Authors:  W R van Dijk; M J van Haperen; S Z Stefanko; A W van der Kamp
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.